In April, Christina Black heard the words every cancer patient dreads: “We’ve run out of treatments. There is nothing else we can give you.” A doctor had just explained that Christina’s latest scan had revealed that tumours which had spread from her breast to her liver, lungs and spine had grown. This meant her treatment was no longer working, and there were no more options left.
Christina, 63, says: “It was devastating. I was clinging to my husband Paul and crying. I remember saying, ‘What do I do now?’ I had to discuss my end-of-life wishes and was put in touch with the palliative care team at the hospital.”
Yet months on Christine is not just alive and well, but her previously unstoppable tumours are shrinking. Why? Because she is taking a remarkable life-extending breast cancer drug called Enhertu. The downside? The NHS refuses to fund it. That means Christina and Paul, 64, from Liverpool, are being forced to spend their pensions and life savings to pay for the £87,000a-year drug.
“It’s a horrible situation,” says Christina, her voice cracking with emotion. “Enhertu is the difference between life and death for me. But we don’t know how long we can continue to pay for the treatment.”
Christina was first diagnosed with breast cancer in 1997 at the age of 36. “It was an emotional time,” she recalls. “I was a single mum at the time, and I had to stay strong for my son, Marc, who was 14.”
In spite of surgery and radiotherapy, Christina’s cancer recurred in 2005, with tumours now growing in her collarbone and neck. Over the next two decades, despite 87 rounds of chemotherapy, more than half a dozen different drugs and a mastectomy in 2016, the disease spread throughout her body. As well as the internal tumours that left her out of breath and exhausted, there were cancer cells in her skin at the site of Christina’s mastectomy.
Diese Geschichte stammt aus der October 10, 2024-Ausgabe von The Independent.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der October 10, 2024-Ausgabe von The Independent.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
We can't stand Musk but he astounded us all this week
I have a confession to make: for a brief moment this week, I became a fully paid-up Elon Musk fanboy.
Saka chasing down the most elusive and weirdest record
With seven assists in as many matches to start the Premier League, is the single-season target of 20 within his reach?
MG dismiss dip in demand for EVs as its sales surge
Carmaker MG has insisted that a drop in electric car interest is “short term” as sales of its vehicles surged last year in the UK.
True story of the killer who appeared on a dating show
Netflix film Woman of the Hour’ is based on the life of serial killer Rodney Alcala, a man who was invited on a gameshow for primetime television and won. Words: Annabel Nugent
Greatest sequel of all time?
Once described as having an overstuffed plot’, Back to the Future 2’ is now up there with the second Terminator’ and Godfather’. Geoffrey Macnab goes back to see what changed
Payne drew the short straw in One Direction; now we'll never know the real him
In and out of the boy band, Liam Payne struggled to find a defining identity, writes Mark Beaumont. His life now cut tragically short, the singer is likely to remain elusive forever
Zelensky tells EU and Nato to back his 'victory plan'
Ukraine president pushes for invitation to military alliance
US stealth bombers strike Houthi bunkers in Yemen
US B-2 stealth bombers have been used against the Iran-backed Houthis for the first time in an escalation of Washington’s response to attacks on shipping in the Red Sea that serves as a message to Tehran.
Does Sinwar's death mean Israel's war in Gaza is over?
For years before he rose to become overall leader of Hamas this summer, Yahya Sinwar had consolidated his power, giving him outsized reach compared to other commanders.
Architect of 7 October raid killed in Gaza, Israel says
Yahya Sinwar, Hamas chief and Israel’s most wanted man, is said to have been killed in a chance encounter with troops